From Lab to Clinic: Controlled Drug Delivery Mechanisms and Translational Challenges

Authors

  • Pinky Jaiswal
  • Shaily Chaudhary
  • Madhuri Muwel
  • Mahima Fareliya
  • Mahak Dueby
  • Mayuri Mulewa
  • Lucky Dhakad
  • Mohit Choyal
  • Lakhan Nagar
  • Akash Yadav

Keywords:

Controlled Drug Delivery Systems, Pharmacokinetics, Pharmacodynamics, 3D Printing, Nanoparticle-Based Delivery

Abstract

Controlled drug delivery systems (CDDS) are designed to release therapeutic agents at precise rates, locations, and durations to enhance treatment efficacy and minimize side effects. Traditional drug delivery methods have several limitations, including high dosage frequency, difficulty in dose monitoring, and non-specific administration. CDDS address these issues by ensuring targeted delivery, improved bioavailability, and reduced dosing frequency. Excipients play a crucial role in CDDS, with polymers, lubricants, and binding agents being key components. Polymers, both synthetic and natural, help regulate drug release, enhance stability, and improve patient compliance. CDDS function based on various mechanisms, including dissolution-controlled, diffusion-controlled, and water penetration-controlled systems. Advanced techniques such as nanoparticle-based delivery, osmotic-controlled systems, and biodegradable polymers further enhance drug delivery efficiency. Pharmacokinetics and pharmacodynamics govern drug absorption, distribution, metabolism, and excretion, influencing bioavailability and therapeutic outcomes. Factors such as molecular weight, solubility, partition coefficient, and pKa affect drug performance in controlled formulations. Compared to conventional drug delivery systems, CDDS maintain plasma drug concentration within the therapeutic window, reducing toxicity risks and enhancing patient compliance. Applications of CDDS span multiple medical fields, including chronic disease management, neurological disorders, hormone therapy, cardiovascular treatments, and antibiotic delivery. Emerging technologies such as nano-medicine, microfluidics, molecularly imprinted polymers, CRISPR/Cas9, and quantum sensing are revolutionizing drug delivery. Additionally, advancements in 3D printing enable customized dosage forms tailored to patient needs. Despite these advancements, challenges remain, including potential toxicity, formulation complexity, and high production costs. Future research aims to improve biocompatibility, develop intelligent biomaterials, and refine personalized medicine approaches. The continuous evolution of CDDS holds promise for more effective and patient-friendly therapeutic solutions.

Downloads

Download data is not yet available.

References

Langer, R. Drug delivery and targeting. Nature 1998, 392, 5–10.

Chaudhari S.P., Patil P.S. Pharmaceutical excipients: A review. IJAPBC. 2012;1:21–34.

Aggarwal S, Goel A, Singla S, Drug Delivary: Special Emphasis Given On Bioderadable Polymers, Advances in Polymer Science and Technology: An International Journal, 2012, 2(1), 1-15

Shargel, L.; Andrew, B.; Wu-Pong, S. Applied Biopharmaceutics & Pharmacokinetics; Appleton & Lange Stamford: Stamford, UK, 1999; Volume 264.

Jambhekar, S.S.; Breen, P.J. Basic Pharmacokinetics; Pharmaceutical Press: London, UK, 2009; Volume 76.

Obata, K.; Sugano, K.; Saitoh, R.; Higashida, A.; Nabuchi, Y.; Machida, M.; Aso, Y. Prediction of oral drug absorption in humans by theoretical passive absorption model. Int. J. Pharm. 2005, 293, 183–192.

Seydel, J.K.; Wiese, M. Drug-Membrane Interactions: Analysis, Drug Distribution, Modeling; John Wiley & Sons: Hoboken, NJ, USA, 2009; Volume 15.

Gillette, J.R. Factors affecting drug metabolism. Ann. N. Y. Acad. Sci. 1971, 179, 43–66.

Ekins, S.; Ring, B.J.; Grace, J.; McRobie-Belle, D.J.; Wrighton, S.A. Present and future in vitro approaches for drug metabolism. J. Pharmacol. Toxicol. Methods 2000, 44, 313–324.

Taft, D.R. Drug excretion. In Pharmacology; Elsevier: Amsterdam, The Netherlands, 2009; pp. 175–199

Reinberg, A.E. Concepts of circadian chronopharmacology. Ann. N. Y. Acad. Sci. 1991, 618, 102–115.

Prabu, S.L.; Suriyaprakash, T.; Ruckmani, K.; Thirumurugan, R. Biopharmaceutics and Pharmacokinetics. In Basic Pharmacokinetic Concepts and Some Clinical Applications; IntechOpen: London, UK, 2015.

Hallare, J.; Gerriets, V. Half Life; StatPearls Publishing LLC: Treasure Island, FL, USA, 2020

Gupta, B.P.; Thakur, N.; Jain, N.P.; Banweer, J.; Jain, S. Osmotically controlled drug delivery system with associated drugs. J. Pharm. Pharm. Sci. 2010, 13, 571–588.

Wang, Z.; Shmeis, R.A. Dissolution controlled drug delivery systems. Des. Control. Release Drug Deliv. Systems. 2006, 139–172

Siepmann, J.; Siegel, R.A.; Siepmann, F. Diffusion controlled drug delivery systems. In Fundamentals and Applications of Controlled Release Drug Delivery; Springer: Berlin/Heidelberg, Germany, 2012; pp. 127–152.

Siepmann, J.; Siepmann, F. Modeling of diffusion controlled drug delivery. J. Control. Release 2012, 161, 351–362

Srikonda, S.; Kotamraj, P.; Barclay, B. Osmotic controlled drug delivery systems. Des. Control. Release Drug Deliv. Syst. 2006, 1, 203.

Siepmann, J.; Siepmann, F. Swelling controlled drug delivery systems. In Fundamentals and Applications of Controlled Release Drug Delivery; Springer: Berlin/Heidelberg, Germany, 2012; pp. 153–170.

Kopeček, J. Polymer–drug conjugates: Origins, progress to date and future directions. Adv. Drug Deliv. Rev. 2013, 65, 49–59.

Michal J. Rathbone, J. Hadgraft, M. Roberts, 2nd edition, Modified-Release Drug Delivery Technology, 2012, PP. 567-578.

Hardenia, A.; Maheshwari, N.; Hardenia, S.S.; Dwivedi, S.K.; Maheshwari, R.; Tekade, R.K. Scientific rationale for designing controlled drug delivery systems. In Basic Fundamentals of Drug Delivery; Elsevier: Amsterdam, The Netherlands, 2019; pp. 1–28.

Bartucci, R.; Paramanandana, A.; Boersma, Y.L.; Olinga, P.; Salvati, A. Comparative study of nanoparticle uptake and impact in murine lung, liver and kidney tissue slices. Nanotoxicology 2020, 14, 847–865.

Lu, L.; Qi, S.; Chen, Y.; Luo, H.; Huang, S.; Yu, X.; Luo, Q.; Zhang, Z. Targeted immunomodulation of inflammatory monocytes across the blood-brain barrier by curcumin-loaded nanoparticles delays the progression of experimental autoimmune encephalomyelitis. Biomaterials 2020, 245, 119987.

Hassan, S.; Zhang, Y.S. Chapter 10—Microfluidic technologies for local drug delivery. In Microfluidics for Pharmaceutical Applications; Santos, H.A., Liu, D., Zhang, H., Eds.; William Andrew Publishing: Amsterdam, The Netherlands, 2019; pp. 281–305.

Zaidi, S.A. Molecular imprinting: A useful approach for drug delivery. Mater. Sci. Energy Technol. 2020, 3, 72–77.

Saylan, Y.; Akgönüllü, S.; Yavuz, H.; Ünal, S.; Denizli, A. Molecularly imprinted polymer based sensors for medical applications. Sensors 2019, 19, 1279.

Mogoşanu, G.D.; Grumezescu, A.M.; Bejenaru, L.E.; Bejenaru, C. Chapter 8—Natural and synthetic polymers for drug delivery and targeting. In Nanobiomaterials in Drug Delivery; Grumezescu, A.M., Ed.; William Andrew Publishing: Amsterdam, The Netherlands, 2016; pp. 229–284.

Wei, T.; Cheng, Q.; Min, Y.-L.; Olson, E.N.; Siegwart, D.J. Systemic nanoparticle delivery of CRISPR-Cas9 ribonucleoproteins for effective tissue specific genome editing. Nat. Commun. 2020, 11, 3232.

Subham Jain, N.; Preeti, S.; Amit, B.P. Application of Quantum Dots in Drug Delivery. Nanosci. Nanotechnol. Asia 2021, 11, 1–16.

Beg, S.; Almalki, W.H.; Malik, A.; Farhan, M.; Aatif, M.; Alharbi, K.S.; Alruwaili, N.K.; Alrobaian, M.; Tarique, M.; Rahman, M. 3D printing for drug delivery and biomedical applications. Drug Discov. Today 2020, 25, 1668–1681.

Trenfield, S.J.; Awad, A.; Madla, C.M.; Hatton, G.B.; Firth, J.; Goyanes, A.; Gaisford, S.; Basit, A.W. Shaping the future: Recent advances of 3D printing in drug delivery and healthcare. Expert Opin. Drug Deliv. 2019, 16, 1081–1094.

Downloads

Published

2025-07-07

How to Cite

1.
Jaiswal P, Chaudhary S, Muwel M, Fareliya M, Dueby M, Mulewa M, et al. From Lab to Clinic: Controlled Drug Delivery Mechanisms and Translational Challenges. J Neonatal Surg [Internet]. 2025 Jul. 7 [cited 2026 Apr. 14];14(32S):4008-119. Available from: https://jneonatalsurg.com/index.php/jns/article/view/8062

Issue

Vol. 14 No. 32S (2025): Journal of Neonatal Surgery

Section

Original Article

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

You are free to:

  • Adapt — remix, transform, and build upon the material for any purpose, even commercially.

Terms:

  • Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.